Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.22.0.1
Stock-Based Compensation (Tables)
9 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Employee stock-based compensation expense
                               
    Three Months Ended December 31,     Nine Months Ended December 31,  
(In thousands)   2021     2020     2021     2020  
Cost of revenues   $     $     $     $ (27 )
Research and development                       26  
Selling, general and administrative     56       93       170       317  
Total stock-based compensation   $ 56     $ 93     $ 170     $ 316  
Schedule of option activity
                               
    Number of
Shares
    Weighted-
Average
Exercise Price
    Weighted-
Average
Contractual Term
    Aggregate
Intrinsic
Value
 
Outstanding at April 1, 2021     267,569     $ 25.16           $  
Options granted                        
Options exercised     (44,042 )     4.38             154,597  
Options forfeited     (3,500 )     8.03              
Options expired     (13,996 )     96.25              
Outstanding at December 31, 2021     206,031     $ 25.06       7.47     $ 8,152  
Exercisable at December 31, 2021     86,200     $ 48.74       5.32     $ 8,152  
Schedule of unvested restricted stock activity
               
   

Number of

Shares

   

Weighted

Average Award

Date Fair Value

per Share

 
Unvested restricted stock awards outstanding at April 1, 2021     833     $ 13.68  
Restricted stock awards granted            
Restricted stock awards vested     833       13.68  
Restricted stock awards forfeited            
Unvested restricted stock awards outstanding at December 31, 2021         $